Find link

langauge:

jump to random article

Find link is a tool written by Edward Betts.

searching for Abciximab 8 found (30 total)

alternate case: abciximab

Downstream processing (635 words) [view diff] exact match in snippet view article find links to article

insulin and humans growth hormone), antibodies (e.g. infliximab and abciximab) and vaccines; antibodies and enzymes used in diagnostics; industrial
Cytochalasin (880 words) [view diff] exact match in snippet view article find links to article
Rehak, P.; März, W.; Halwachs-Baumann, G. (2004). "Different effects of abciximab and cytochalasin D on clot strength in thrombelastography". Journal of
Reperfusion therapy (3,428 words) [view diff] exact match in snippet view article find links to article
(2003). "Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to
Schedule H (262 words) [view diff] case mismatch in snippet view article find links to article
1. ABACAVIR 2. ABCIXIMAB 3. ACAMPROSATE CALCIUM 4. ACEBUTOL HYDROCHLORIDE 5. ACLARUBICIN 6. ALBENDAZOLE 7. ALCLOMETASONE DIPROPIONATE 8. ACTILYSE 9. ACYCLOVIR
Scaar (507 words) [view diff] exact match in snippet view article find links to article
Per Tornvall, Tage Nilsson and Bo Lagerqvist. Effects on mortality of abciximab in ST-elevation myocardial infarction treated with percutaneous coronary
Harvey Berger (1,586 words) [view diff] exact match in snippet view article find links to article
Crohn's disease, ulcerative colitis and rheumatoid arthritis, ReoPro® (abciximab), formerly known as CentoRx, a drug for the prevention of ischemic complications
Thromboelastometry (2,460 words) [view diff] exact match in snippet view article find links to article
Metzler H, Rehak P, März W, Halwachs-Baumann G. Different effects of abciximab and cytochalasin D on clot strength in thrombelastography. J Thromb Haemost
James H. Ware (2,000 words) [view diff] exact match in snippet view article find links to article
Lansky AJ, Stone GW. Comparison of catheterization laboratory initiated abciximab and eptifibatide during percutaneous coronary intervention in acute coronary